Aptamers as functional nucleic acids:In vitro selection and biotechnological applications
暂无分享,去创建一个
[1] H. Goodman,et al. Design of highly specific cytotoxins by using trans-splicing ribozymes. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[3] F. Ducongé,et al. In vitro selection identifies key determinants for loop-loop interactions: RNA aptamers selective for the TAR RNA element of HIV-1. , 1999, RNA.
[4] N. Janjić,et al. Novel approach to specific growth factor inhibition in vivo: antagonism of platelet-derived growth factor in glomerulonephritis by aptamers. , 1999, The American journal of pathology.
[5] I. Majerfeld,et al. An RNA pocket for an aliphatic hydrophobe , 1994, Nature Structural Biology.
[6] S. Watson,et al. Isolation and characterization of 2'-fluoro-, 2'-amino-, and 2'-fluoro-/amino-modified RNA ligands to human IFN-gamma that inhibit receptor binding. , 1997, Journal of immunology.
[7] G. Tocchini-Valentini,et al. In vitro selection of dopamine RNA ligands. , 1997, Biochemistry.
[8] S D Jayasena,et al. Use of a high affinity DNA ligand in flow cytometry. , 1996, Nucleic acids research.
[9] A. Ellington,et al. RNA Molecules That Bind to and Inhibit the Active Site of a Tyrosine Phosphatase* , 1998, The Journal of Biological Chemistry.
[10] N. Sugimoto,et al. In vitro selection of aptamers that act with Zn2+. , 2000, Journal of inorganic biochemistry.
[11] C. Wilson,et al. 2.8 A crystal structure of the malachite green aptamer. , 2000, Journal of molecular biology.
[12] Penmetcha K. R. Kumar,et al. Molecular beacon aptamer fluoresces in the presence of Tat protein of HIV‐1 , 2000, Genes to cells : devoted to molecular & cellular mechanisms.
[13] Sheela M. Waugh,et al. 2′-Fluoropyrimidine RNA-based Aptamers to the 165-Amino Acid Form of Vascular Endothelial Growth Factor (VEGF165) , 1998, The Journal of Biological Chemistry.
[14] B. Sullenger,et al. Enhancing RNA repair efficiency by combining trans-splicing ribozymes that recognize different accessible sites on a target RNA. , 2000, Molecular therapy : the journal of the American Society of Gene Therapy.
[15] A. Pardi,et al. A semiconserved residue inhibits complex formation by stabilizing interactions in the free state of a theophylline-binding RNA. , 1998, Biochemistry.
[16] T. Parslow,et al. In vitro selection of RNAs that bind to the human immunodeficiency virus type-1 gag polyprotein. , 1997, Nucleic acids research.
[17] A. Ellington,et al. Anti-Rex Aptamers as Mimics of the Rex-Binding Element , 1999, Journal of Virology.
[18] SELEX selection of high-affinity oligonucleotides for bacteriophage Ff gene 5 protein. , 2001, Biochemistry.
[19] A. Varki,et al. DNA aptamers block L-selectin function in vivo. Inhibition of human lymphocyte trafficking in SCID mice. , 1996, The Journal of clinical investigation.
[20] S. Gill,et al. Detection and plasma pharmacokinetics of an anti-vascular endothelial growth factor oligonucleotide-aptamer (NX1838) in rhesus monkeys. , 1999, Journal of chromatography. B, Biomedical sciences and applications.
[21] Joyce Nelson,et al. Pharmacokinetics and Safety of an Anti-Vascular Endothelial Growth Factor Aptamer (NX1838) Following Injection into the Vitreous Humor of Rhesus Monkeys , 2000, Pharmaceutical Research.
[22] C. Berens,et al. A tetracycline-binding RNA aptamer. , 2001, Bioorganic & medicinal chemistry.
[23] V. Remcho,et al. Aptamers as analytical reagents , 2002, Electrophoresis.
[24] E. Vermaas,et al. Selection of single-stranded DNA molecules that bind and inhibit human thrombin , 1992, Nature.
[25] A. Pardi,et al. High-resolution molecular discrimination by RNA. , 1994, Science.
[26] Peptide conjugation to an in vitro-selected DNA ligand improves enzyme inhibition. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[27] D. Lyster,et al. Synthesis and radioiodination of a stannyl oligodeoxyribonucleotide. , 1997, Nucleic acids research.
[28] S. Ringquist,et al. Anti-L-selectin oligonucleotide ligands recognize CD62L-positive leukocytes: binding affinity and specificity of univalent and bivalent ligands. , 1998, Cytometry.
[29] David R. Liu,et al. Nucleic acid evolution and minimization by nonhomologous random recombination , 2002, Nature Biotechnology.
[30] Dinshaw J. Patel,et al. Solution structure of the tobramycin–RNA aptamer complex , 1998, Nature Structural Biology.
[31] M. Green,et al. Controlling gene expression in living cells through small molecule-RNA interactions. , 1998, Science.
[32] D. Drolet,et al. Aptamer affinity chromatography: combinatorial chemistry applied to protein purification. , 1999, Journal of chromatography. B, Biomedical sciences and applications.
[33] S. Yokoyama,et al. RNA aptamers that specifically bind to the Ras‐binding domain of Raf‐1 , 1998, FEBS letters.
[34] L. McGown,et al. Separation of nontarget compounds by DNA aptamers. , 2000, Analytical chemistry.
[35] B. Sullenger,et al. Developing aptamers into therapeutics. , 2000, The Journal of clinical investigation.
[36] T. Fitzwater,et al. A SELEX primer. , 1996, Methods in enzymology.
[37] P. Burgstaller,et al. RNA aptamers that bind L-arginine with sub-micromolar dissociation constants and high enantioselectivity. , 1996, Nucleic acids research.
[38] Volker A. Erdmann,et al. High-affinity RNA as a recognition element in a biosensor , 1998 .
[39] J. Szostak,et al. A DNA aptamer that binds adenosine and ATP. , 1995, Biochemistry.
[40] A. Karpeisky,et al. Chemical Modification of Hammerhead Ribozymes , 1995, The Journal of Biological Chemistry.
[41] B. Sullenger,et al. Blocking the Initiation of Coagulation by RNA Aptamers to Factor VIIa , 2000, Thrombosis and Haemostasis.
[42] F. Liu,et al. In vitro selection of novel RNA ligands that bind human cytomegalovirus and block viral infection. , 2000, RNA.
[43] D. Patel,et al. Structural analysis of nucleic acid aptamers. , 1997, Current opinion in chemical biology.
[44] A. Barclay,et al. Cutting edge: novel RNA ligands able to bind CD4 antigen and inhibit CD4+ T lymphocyte function. , 1998, Journal of immunology.
[45] J C Cox,et al. Automated RNA Selection , 1998, Biotechnology progress.
[46] Jon R. Lorsch,et al. In vitro evolution of new ribozymes with polynucleotide kinase activity , 1994, Nature.
[47] P Sarnow,et al. In vitro selection of a 7-methyl-guanosine binding RNA that inhibits translation of capped mRNA molecules. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[48] M. Willis,et al. Diagnostic potential of PhotoSELEX-evolved ssDNA aptamers. , 2000, Journal of biotechnology.
[49] R. Kennedy,et al. Aptamers as ligands in affinity probe capillary electrophoresis. , 1998, Analytical chemistry.
[50] Bing Li,et al. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo , 1993, Nature.
[51] R. Seibl,et al. Nonradioactive 3'-end-labeling of RNA molecules of different lengths by terminal deoxynucleotidyltransferase. , 1995, Analytical biochemistry.
[52] A. Ellington,et al. Adapting selected nucleic acid ligands (aptamers) to biosensors. , 1998, Analytical chemistry.
[53] A simple method for 3'-labeling of RNA. , 1996, Nucleic acids research.
[54] T. Zhang,et al. Liposome-anchored vascular endothelial growth factor aptamers. , 1998, Bioconjugate chemistry.
[55] W. Stemmer. Rapid evolution of a protein in vitro by DNA shuffling , 1994, Nature.
[56] G. Tocchini-Valentini,et al. tRNA prefers to kiss , 1999, The EMBO journal.
[57] C. O’Sullivan. Aptasensors – the future of biosensing? , 2002, Analytical and bioanalytical chemistry.
[58] A. Aitken,et al. The Generation and Characterization of Antagonist RNA Aptamers to Human Oncostatin M* , 2000, The Journal of Biological Chemistry.
[59] A. Frankel,et al. Identification of two novel arginine binding DNAs. , 1995, The EMBO journal.
[60] K. Gebhardt,et al. RNA aptamers to S-adenosylhomocysteine: kinetic properties, divalent cation dependency, and comparison with anti-S-adenosylhomocysteine antibody. , 2000, Biochemistry.
[61] J. Latham,et al. The application of a modified nucleotide in aptamer selection: novel thrombin aptamers containing 5-(1-pentynyl)-2'-deoxyuridine. , 1994, Nucleic acids research.
[62] Jack W. Szostak,et al. An RNA motif that binds ATP , 1993, Nature.
[63] Michael Famulok,et al. Stereospecific recognition of tryptophan agarose by in vitro selected RNA , 1992 .
[64] L. Gold,et al. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. , 1990, Science.
[65] J. Szostak,et al. Selection in vitro of single-stranded DNA molecules that fold into specific ligand-binding structures , 1992, Nature.
[66] M. Famulok,et al. Characterization and divalent metal-ion dependence of in vitro selected deoxyribozymes which cleave DNA/RNA chimeric oligonucleotides. , 1997, Journal of molecular biology.
[67] D. Patel,et al. Saccharide-RNA recognition in a complex formed between neomycin B and an RNA aptamer. , 1999, Structure.
[68] Y. Okuno,et al. Allosteric regulation of a ribozyme activity through ligand-induced conformational change. , 1998, Nucleic acids research.
[69] R. Kennedy,et al. Retention and separation of adenosine and analogues by affinity chromatography with an aptamer stationary phase. , 2001, Analytical chemistry.
[70] M. Famulok,et al. RNA aptamers specifically interact with the prion protein PrP , 1997, Journal of virology.
[71] S D Jayasena,et al. Staining of cell surface human CD4 with 2'-F-pyrimidine-containing RNA aptamers for flow cytometry. , 1998, Nucleic acids research.
[72] Wei-xing Li,et al. A novel nucleotide-based thrombin inhibitor inhibits clot-bound thrombin and reduces arterial platelet thrombus formation , 1994 .
[73] J. Kinet,et al. High-affinity oligonucleotide ligands to human IgE inhibit binding to Fc epsilon receptor I. , 1996, Journal of immunology.
[74] J. Szostak,et al. In vitro selection of RNA molecules that bind specific ligands , 1990, Nature.
[75] Alan Dove,et al. Proteomics: translating genomics into products? , 1999, Nature Biotechnology.
[76] R. Schroeder,et al. StreptoTag: a novel method for the isolation of RNA-binding proteins. , 1999, RNA.
[77] Anthony D. Keefe,et al. The use of mRNA display to select high-affinity protein-binding peptides , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[78] M F Kubik,et al. Oligonucleotide inhibitors of human thrombin that bind distinct epitopes. , 1997, Journal of molecular biology.
[79] Gerald F. Joyce,et al. Selection in vitro of an RNA enzyme that specifically cleaves single-stranded DNA , 1990, Nature.
[80] A D Ellington,et al. In Vitro Selection of RNA Molecules That Inhibit the Activity of Ricin A-chain* , 2000, The Journal of Biological Chemistry.
[81] H. Steinhoff,et al. HIV-1 Reverse Transcriptase-Pseudoknot RNA Aptamer Interaction Has a Binding Affinity in the Low Picomolar Range Coupled with High Specificity* , 2000, The Journal of Biological Chemistry.
[82] D. Drolet,et al. An enzyme-linked oligonucleotide assay , 1996, Nature Biotechnology.
[83] Charles Wilson,et al. The structural basis for molecular recognition by the vitamin B 12 RNA aptamer , 2000, Nature Structural Biology.
[84] K. Shimotohno,et al. The RNA aptamer-binding site of hepatitis C virus NS3 protease. , 2000, Biochemical and biophysical research communications.
[85] D. Walt,et al. A fiber-optic microarray biosensor using aptamers as receptors. , 2000, Analytical biochemistry.
[86] J. Szostak,et al. In vitro selection of RNA aptamers specific for cyanocobalamin. , 1994, Biochemistry.
[87] C. Vargeese,et al. Potent 2'-amino-2'-deoxypyrimidine RNA inhibitors of basic fibroblast growth factor. , 1995, Biochemistry.
[88] C R Cantor,et al. High-density, covalent attachment of DNA to silicon wafers for analysis by maldi-tof mass spectrometry. , 1997, Analytical chemistry.
[89] L. McGown,et al. Open‐tubular capillary electrochromatography of bovine β‐lactoglobulin variants A and B using an aptamer stationary phase , 2001, Electrophoresis.
[90] G. Lowe. Oligomeric and biogenetic combinatorial libraries. , 1999, Natural product reports.
[91] A D Ellington,et al. Aptamers as therapeutic and diagnostic reagents: problems and prospects. , 1997, Current opinion in chemical biology.
[92] J. Szostak,et al. Functional requirements for specific ligand recognition by a biotin-binding RNA pseudoknot. , 1998, Biochemistry.
[93] S Lee,et al. In vitro selection of the RNA aptamer against the Sialyl Lewis X and its inhibition of the cell adhesion. , 2001, Biochemical and biophysical research communications.
[94] W. James,et al. Nucleic acid and polypeptide aptamers: a powerful approach to ligand discovery. , 2001, Current opinion in pharmacology.
[95] A. Ellington,et al. In vitro selection of RNA lectins: using combinatorial chemistry to interpret ribozyme evolution. , 1995, Chemistry & biology.
[96] S. Jayasena. Aptamers: an emerging class of molecules that rival antibodies in diagnostics. , 1999, Clinical chemistry.
[97] Q. Yu,et al. Cleavage of Highly Structured Viral RNA Molecules by Combinatorial Libraries of Hairpin Ribozymes , 1998, The Journal of Biological Chemistry.